Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History DYAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics DYAI

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Dyadic International Inc

DYAI
Current price
0.94 USD -0.012 USD (-1.26%)
Last closed 0.91 USD
ISIN US26745T1016
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 27 442 718 USD
Yield for 12 month -41.01 %
1Y
3Y
5Y
10Y
15Y
DYAI
21.11.2021 - 28.11.2021

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally. It utilizes the C1 platform in pharmaceutical applications, including the development and production of pharmaceutical products. The company offers Dapibus, a protein production platform that enable the rapid development and large-scale manufacture of cost-effective enzymes, proteins, metabolites, and other biologic products for life sciences, food and nutrition, and bioindustrial applications. In addition, it develops DYAI-100, a C1-SARS-CoV-2 recombinant protein RBD vaccine candidate and first C1, which is in phase 1 clinical trial to produce protein tested in humans. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa's Rubic One Health; joint development agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida. Address: 1044 North U.S. Highway One, Jupiter, FL, United States, 33477-5094

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

9.00 USD

P/E ratio

Dividend Yield

Financials DYAI

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures DYAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+3 495 389 USD

Last Year

+2 898 806 USD

Current Quarter

+393 572 USD

Last Quarter

+817 376 USD

Current Year

+2 300 765 USD

Last Year

+922 957 USD

Current Quarter

+267 092 USD

Last Quarter

+464 557 USD
EBITDA
Operating Margin TTM -507.00 %
Price to Earnings
Return On Assets TTM -34.95 %
PEG Ratio
Return On Equity TTM -214.26 %
Wall Street Target Price 9.00 USD
Revenue TTM 3 554 344 USD
Book Value 0.031 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 17.60 %
Dividend Yield
Gross Profit TTM 2 206 017 USD
Earnings per share -0.20 USD
Diluted Eps TTM -0.20 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -163.94 %

Stock Valuation DYAI

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 15.82
Enterprise Value Revenue 7.68
Price Sales TTM 7.72
Enterprise Value EBITDA -2.93
Price Book MRQ 30.29

Technical indicators DYAI

For 52 weeks

0.91 USD 2.20 USD
50 Day MA 1.08 USD
Shares Short Prior Month 151 629
200 Day MA 1.32 USD
Short Ratio 3.74
Shares Short 166 634
Short Percent 0.76 %